AI

MRI-specific AI algorithm reads cardiac scans with up to 99% accuracy
By Kate Madden Yee
The algorithm beat existing general-purpose AI models by up to 35%, researchers reported.
May 21, 2026
Cardiac Mri Adobe Samunella
Neurophet names imaging AI expert Tanenbaum as scientific advisor
By AuntMinnie.com staff writers
Neurophet has appointed neuroradiologist Lawrence Tanenbaum, MD, as scientific advisor.
May 21, 2026
Lawrence Tanenbaum, MD
Podcast: The PACSMan Pontificates, Episode 2 -- RFPs
By Michael J. Cannavo
Are RFPs still needed for buying a PACS? Michael J. Cannavo, aka the PACSMan, tackles this question in episode 2 of The PACSMan Pontificates podcast series.
May 20, 2026
Pacsman Pontification
Human-AI collaboration beats AI alone for identifying PE
By Kate Madden Yee
Study findings highlight the continued central role of radiologists for this indication.
May 20, 2026
Case example of a false-negative AI result. An 85-year-old female presented to the emergency department with dyspnea. Axial 0.625-mm from CT pulmonary angiography examination with contrast (CTPA) images demonstrate a thin, linear right-sided filling defect extending from the right interlobar pulmonary artery (A and B, red arrows) into the right middle lobar artery (B, yellow arrow), consistent with acute pulmonary embolism (PE). The finding was described in the radiology report; however, the AI result was negative for PE. Adjudication was consistent with acute PE.
AI model predicts 10-year breast cancer risk
By Amerigo Allegretto
A mammography-based AI model showed strong performance in predicting 10-year breast cancer risk over clinical and other AI models.
May 20, 2026
Breast Cancer3
DeepHealth secures FDA clearance, CE marking for neuro, prostate AI
By AuntMinnie.com staff writers
The company has won multiple regulatory clearances for neuro, prostate, and lumbar MRI AI.
May 20, 2026
Ai Hand
Azra AI, RevealDx announce partnership
By AuntMinnie.com staff writers
The partnership builds on Azra AI's recent acquisition of Thynk Health.
May 20, 2026
Ai Handshake
AI devices vary widely in lung cancer detection
By Will Morton
Three devices helped detect more cancerous tumors, whereas the other four devices helped detect fewer tumors.
May 19, 2026
Cropped secondary capture examples. These are illustrative and not intended to imply superiority or inferiority of any device. (A) Posteroanterior radiograph in a 46-year-old female patient. The device correctly identified a right lower lobe nodule projected below the right hemidiaphragm and hilar lymphadenopathy. (B) Posteroanterior radiograph in an 86-year-old female patient with a classic Golden S sign highly suggestive of cancer. Three devices did not identify any findings. (C) The output from one device for the same radiograph as in B. The device placed a contour around the area of abnormality but mislabeled it as segmental collapse, and there are no other elements in the output to raise suspicion of cancer. (D) Posteroanterior radiograph in a 60-year-old male patient -- a case of confirmed lung cancer that was not deemed visible in retrospect. The device identified multiple false-positive abnormalities. (E) Posteroanterior radiograph in a 77-year-old female patient with two right lower lobe nodules. The device mislabeled the abnormality as infection -- a diagnostic term that could incorrectly influence clinical management. (F) Posteroanterior radiograph in a 77-year-old female patient with a right hilar tumor. Most of the lungs have been labeled by the device, with excessive overlap of the abnormality that pragmatically represents an incorrect result. All annotations shown were produced by the devices. LL = lung lesion, LO = lung opacity, PO = pleural other, TBC = tuberculosis.
GE HealthCare opens free AI training program
By AuntMinnie.com staff writers
The company is making more than 20 hours of AI education available at no cost through its HelloAI program.
May 19, 2026
Ai 1
HOPPR launches mammography vision-language model
By AuntMinnie.com staff writers
The model was trained on more than 200,000 mammography studies from multiple U.S. sites.
May 19, 2026
Ai2
MRI-based ML model shows promise in colorectal cancer subtyping
By Amerigo Allegretto
A machine-learning model based on MRI radiomics achieved high performance in predicting colorectal cancer subtypes.
May 19, 2026
Overview of the study design, including data collection, radiomics model construction, and biologic interpretation. (A) The primary cohort for model development and evaluation in the training and internal test sets includes 168 patients with colorectal cancer (CRC) from center 1 (Fudan University Shanghai Cancer Center), whereas external testing was performed using data from 85 patients from centers 2 (Huashan Hospital, Fudan University) and 3 (Zhongshan Hospital, Fudan University). For model interpretation, RNA sequencing (RNA-seq) data from 18 patients with CRC in center 1 and single-cell data from 35 patients from the Gene Expression Omnibus (GEO) database are incorporated. Mismatch repair (MMR) protein expression, obtained from pathologic reports in electronic medical records (EMRs), was used to identify patients with consensus molecular subtype 1 (CMS1) CRC. Tissue microarrays (TMAs) from surgically obtained CRC tissues were analyzed for immunohistochemical staining of caudal-type homeobox 2 (CDX2), 5-hydroxytryptamine receptor 2B (HTR2B), FERM domain containing 6 (FRMD6), and zinc finger E-box binding homeobox 1 (ZEB1), and the results were subsequently entered into an online classification tool that assigned patients to CMS2, 3, or 4 subtypes. (B) Radiomics workflow for CMS4 prediction. Lesions were manually delineated on T2-weighted imaging (T2WI) and contrast-enhanced (CE) T1-weighted imaging (T1WI), followed by radiomics feature extraction. Feature selection and model development were performed in the training set using machine-learning algorithms with fivefold cross-validation for model selection, and the final model was evaluated in the internal and external test sets using receiver operating characteristic (ROC) curve analysis. (C) Transcriptomic interpretation workflow. Using the radiomics-predicted CMS4 classification, bulk RNA sequencing (RNA-seq) data were used to perform differential expression analysis between predicted CMS4 and non-CMS4 groups, followed by pathway enrichment analyses to assess biologic relevance. Public single-cell RNA sequencing data from the Gene Expression Omnibus database were then used for cell-type–level interrogation to support interpretation of the associated pathways.
Viz.ai launches pulmonary AI suite
By AuntMinnie.com staff writers
The suite integrates acute and chronic pulmonary workflows in a single platform.
May 14, 2026
Lungs 2
Page 1 of 409
Next Page